284 related articles for article (PubMed ID: 37690447)
1. Relation between WHO Classification and Location- and Functionality-Based Classifications of Neuroendocrine Neoplasms of the Digestive Tract.
Helderman NC; Suerink M; Kilinç G; van den Berg JG; Nielsen M; Tesselaar MET
Neuroendocrinology; 2024; 114(2):120-133. PubMed ID: 37690447
[TBL] [Abstract][Full Text] [Related]
2. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
Klöppel G
Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications.
Klöppel G
Visc Med; 2017 Oct; 33(5):324-330. PubMed ID: 29177160
[TBL] [Abstract][Full Text] [Related]
5. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs.
Park HK; Kwon GY
J Korean Med Sci; 2023 Mar; 38(11):e85. PubMed ID: 36942393
[TBL] [Abstract][Full Text] [Related]
7. The classification of neuroendocrine neoplasms of the breast and its clinical relevance.
Uccella S
Virchows Arch; 2022 Jul; 481(1):3-12. PubMed ID: 34698887
[TBL] [Abstract][Full Text] [Related]
8. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome.
Metovic J; Cascardi E; Uccella S; Maragliano R; Querzoli G; Osella-Abate S; Pittaro A; La Rosa S; Bogina G; Cassoni P; Marchiò C; Sapino A; Castellano I; Papotti M
Virchows Arch; 2022 Dec; 481(6):839-846. PubMed ID: 36243799
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological analysis of lung and mediastinal neuroendocrine neoplasms in Japan based on the national database.
Matsuoka S; Koizumi T; Otsuki K; Tanaka Y; Kanda S; Ide S; Mishima S; Takeda T; Miura K; Eguchi T; Hamanaka K; Shimizu K
Cancer Epidemiol; 2022 Apr; 77():102116. PubMed ID: 35144127
[TBL] [Abstract][Full Text] [Related]
11. An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features.
Kasajima A; Konukiewitz B; Schlitter AM; Weichert W; Klöppel G
Virchows Arch; 2022 Feb; 480(2):359-368. PubMed ID: 34499237
[TBL] [Abstract][Full Text] [Related]
12. An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs.
Couvelard A; Cros J
Virchows Arch; 2022 Jun; 480(6):1129-1148. PubMed ID: 35278097
[TBL] [Abstract][Full Text] [Related]
13. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
14. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J
Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650
[TBL] [Abstract][Full Text] [Related]
15. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.
Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M
Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021.
Thiis-Evensen E; Boyar Cetinkaya R
J Neuroendocrinol; 2023 Apr; 35(4):e13264. PubMed ID: 36988112
[TBL] [Abstract][Full Text] [Related]
17. Classification and Prognostic Stratification of Bronchopulmonary Neuroendocrine Neoplasms.
Oka N; Kasajima A; Konukiewitz B; Sakurada A; Okada Y; Kameya T; Weichert W; Ishikawa Y; Suzuki H; Sasano H; Klöppel G
Neuroendocrinology; 2020; 110(5):393-403. PubMed ID: 31422400
[TBL] [Abstract][Full Text] [Related]
18. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification.
Xu JX; Wu DH; Ying LW; Hu HG
World J Gastroenterol; 2021 Dec; 27(47):8123-8137. PubMed ID: 35068858
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of ODF1 in Gastrointestinal Tract Neuroendocrine Neoplasms: a Novel Potential Immunohistochemical Biomarker for Well-differentiated Neuroendocrine Tumors.
Li B; Li X; Mao R; Liu M; Fu L; Shi L; Zhao S; Fu M
Endocr Pathol; 2021 Jun; 32(2):301-308. PubMed ID: 32869188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
